Advisors Preferred’s Gilead Sciences GILD Stock Holding History

Advisors Preferred’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-473	Closed	-$30K	–	267
2019 Q3	$30K	Buy	473 +97	+26%	+$6.34K	0.01%	166
2019 Q2	$26K	Buy	+376	New	+$24.7K	0.01%	176
2019 Q1	–	Sell	-484	Closed	-$31K	–	211
2018 Q4	$31K	Buy	+484	New	+$33.8K	0.04%	105
2018 Q3	–	Sell	-272	Closed	-$19K	–	203
2018 Q2	$19K	Sell	272 -1,580	-85%	-$112K	0.01%	188
2018 Q1	$140K	Buy	+1,852	New	+$147K	0.07%	89
2017 Q3	–	Sell	-899	Closed	-$63K	–	238
2017 Q2	$63K	Buy	+899	New	+$59.8K	0.03%	128
2016 Q2	–	Sell	-161	Closed	-$15K	–	250
2016 Q1	$15K	Buy	+161	New	+$14.5K	0.01%	143
2015 Q1	–	Sell	-961	Closed	-$90.6K	–	290
2014 Q4	$90.6K	Buy	961 +272	+39%	+$28.1K	0.04%	180
2014 Q3	$73.3K	Buy	+689	New	+$67.5K	0.05%	108
2014 Q2	–	Sell	-414	Closed	-$29.3K	–	359
2014 Q1	$29.3K	Buy	+414	New	+$32.5K	0.01%	290

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisors Preferred's GILD Position: Q4 2019 in Review

Advisors Preferred sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 473 shares — an estimated $30K sold.

Advisors Preferred first reported a position in GILD in Q1 2014 and held it in 10 quarters. The position peaked at $140K in Q1 2018. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

Advisors Preferred reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
Advisors Preferred sold 473 Gilead Sciences shares in Q4 2019, an estimated $30K.
Advisors Preferred first reported a position in Gilead Sciences in Q1 2014 and held it in 10 quarters.
Advisors Preferred's Gilead Sciences position peaked at $140K in Q1 2018.
1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Advisors Preferred's 13F filing for Q4 2019, filed 21 Jan 2020.